1.97

4.37% -0.09

After Hours: 1.99 0.02 +1.02%

Sera Prognostics Inc (SERA)

Overview News Price History Financials Discussions Forecast

Sera Prognostics Inc stock is traded at $1.97, with a volume of 15,855. It is down -4.37% in the last 24 hours and down -1.50% over the past month. Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Previous Close:

$2.06

Open:

$2.04

24h Volume:

15,855

Relative Volume:

0.32

Market Cap:

$77.14M

Revenue:

$57,000

Net Income/Loss:

$-32.14M

P/E Ratio:

-3.0467

EPS:

-0.6466

Net Cash Flow:

$-27.58M

1W Performance:

-1.50%

1M Performance:

-1.50%

6M Performance:

-46.61%

1Y Performance:

-28.62%

1-Day Range:

$1.9379

$2.0549

1-Week Range:

$1.7901

$2.12

52-Week Range:

$1.56

$3.95

Sera Prognostics Inc Stock (SERA) Company Profile

Name

Sera Prognostics Inc

Sector

Healthcare (1096)

Industry

Medical Devices (140)

Phone

(801) 990-0520

Address

2749 E. PARLEYS WAY, SALT LAKE CITY

Employee

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

SERA's Discussions on Twitter

Compare SERA vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SERA Sera Prognostics Inc	1.97	77.14M	57,000	-32.14M	-27.58M	-0.6466
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-15-25	Initiated	Jefferies	Buy
Mar-30-22	Downgrade	Citigroup	Buy → Neutral
Nov-19-21	Initiated	Oppenheimer	Outperform
Oct-15-21	Resumed	Cowen	Outperform

Sera Prognostics Inc Stock (SERA) Latest News

Jul 09, 2026

Sera Prognostics study shows NICU admission cut in first births - Investing.com

Jul 09, 2026

Sera Prognostics study shows NICU admission cut in first births By Investing.com - Investing.com Canada

Jul 09, 2026

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE - PR Newswire

Jul 09, 2026

Jul 07, 2026

Sera Prognostics Among 3 Intriguing Penny Stocks To Consider - simplywall.st

Jul 07, 2026

Jul 03, 2026

SERASera Prognostics Inc Options - Finviz

Jul 03, 2026

Jul 01, 2026

Director Mark Christopher Capone files Form 3 for Sera Prognostics (SERA) - Stock Titan

Jul 01, 2026

Sera Prognostics, Inc. Class A Actuals & Estimates (NASDAQ:SERA) - TradingView

Jul 01, 2026

Jun 30, 2026

Sera Prognostics adds former Myriad Genetics CEO to board By Investing.com - Investing.com South Africa

Jun 30, 2026

Sera Prognostics, Inc. Appoints Mark Capone as Class II Director and Member of Compensation Committee, Effective as of July 1, 2026 - marketscreener.com

Jun 30, 2026

Sera Prognostics adds former Myriad Genetics CEO to board - Investing.com

Jun 30, 2026

Sera Prognostics Adds Veteran Executive to Board - TipRanks

Jun 30, 2026

Mark Capone appointed to Sera Prognostics board, joins Compensation Committee - TradingView

Jun 30, 2026

Veteran diagnostics leader Mark Capone joins Sera Prognostics (NASDAQ: SERA) board - Stock Titan

Jun 30, 2026

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS - Aspen Daily News

Jun 30, 2026

Jun 29, 2026

Sera Prognostics (SERA) Edges Higher as Stock Tests Key Resistance LevelStop Run - dars.gov.et

Jun 29, 2026

Sera Prognostics, Inc.(NasdaqGM:SERA) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Sera Prognostics, Inc.(NasdaqGM: SERA) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 25, 2026

Sera Prognostics, Inc. Class A Actuals & Estimates (BOATS:SERA) - TradingView

Jun 25, 2026

SERA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Sera Prognostics (SERA) loses 27% in 4 weeks, here's why a trend reversal may be around the corner - MSN

Jun 25, 2026

Jun 24, 2026

Price to earnings forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView

Jun 24, 2026

Enterprise value to revenue forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView

Jun 24, 2026

Price to sales forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView

Jun 24, 2026

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH - PR Newswire

Jun 24, 2026

Price to book forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView

Jun 24, 2026

Enterprise value to EBIT forward of Sera Prognostics, Inc. – BOATS:SERA - TradingView

Jun 24, 2026

Sera Prognostics joins $10.4M ARPA-H project to develop a rapid test for safer labor and delivery. - Pluang

Jun 24, 2026

Jun 23, 2026

Illinois expands Medicaid coverage for preterm birth tests By Investing.com - Investing.com South Africa

Jun 23, 2026

Illinois expands Medicaid coverage for preterm birth tests - Investing.com UK

Jun 23, 2026

SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY - PR Newswire

Jun 23, 2026

Jun 21, 2026

Sera Prognostics Q1 2026 Earnings: In-Line Loss Highlights Pre-Revenue ProgressOperating Margin Analysis - dars.gov.et

Jun 21, 2026

Jun 20, 2026

All you need to know about Sera Prognostics (SERA) rating upgrade to buy - MSN

Jun 20, 2026

Jun 19, 2026

All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy - Yahoo Finance

Jun 19, 2026

Jun 18, 2026

SERA News | SERA PROGNOSTICS INC-A (NASDAQ:SERA) - ChartMill

Jun 18, 2026